Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases.
about
Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trialsEndogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo.Low serum interleukin-13 levels correlate with poorer prognoses for colorectal cancer patients.Interleukin-4 and interleukin-13 increase NADPH oxidase 1-related proliferation of human colon cancer cells.Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies.Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer.Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatmentIL-13 induces the expression of 11βHSD2 in IL-13Rα2 dependent manner and promotes the malignancy of colorectal cancer.IL-13/STAT6 signaling plays a critical role in the epithelial-mesenchymal transition of colorectal cancer cells.The immune network in pancreatic cancer development and progression.Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.The lymphatic system and pancreatic cancer.mRNA expression profiles obtained from microdissected pancreatic cancer cells can predict patient survival.Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
P2860
Q26781538-D3AADE08-F16F-4555-90AB-E5FFA461CA2CQ33624331-3D00C529-661B-482E-8E87-0F0FBFFE057BQ33636910-161324F9-06CF-41D8-B382-DB33DB4EA41FQ33888701-21549FA9-E1CF-41D8-A41A-E75E190611ACQ34596741-2AD02465-9F58-433B-ADC9-FB26AC4F3249Q35222367-6D9B67BF-E478-4E0B-BE6E-7F080180380EQ36118109-98356810-FF9A-4F81-99BE-80F73D12E055Q36150219-16EC90D2-B2EE-4874-9F97-4C097F4C360AQ36841327-68488CE2-CB6E-4013-824E-8FC7C08C5B1FQ37641580-31900F66-7CFA-4719-BD6F-0E07FD4D3A99Q38121412-651D6CE1-8CA5-4560-9F8A-D5A08172A39FQ38570271-BD7F6688-50A5-436D-8796-602CB4F5FAAAQ38689578-76C8DA28-70D8-4541-A9E7-72C0AAEC5DB1Q47093762-66DDAEAC-33DC-42E3-B170-19668C940FB2Q53478215-F7727E20-EF84-4BDF-83CC-18FC8C194D76
P2860
Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Interleukin-13 exerts autocrin ...... ity for lymph node metastases.
@en
Interleukin-13 exerts autocrin ...... ity for lymph node metastases.
@nl
type
label
Interleukin-13 exerts autocrin ...... ity for lymph node metastases.
@en
Interleukin-13 exerts autocrin ...... ity for lymph node metastases.
@nl
prefLabel
Interleukin-13 exerts autocrin ...... ity for lymph node metastases.
@en
Interleukin-13 exerts autocrin ...... ity for lymph node metastases.
@nl
P2093
P1476
Interleukin-13 exerts autocrin ...... sity for lymph node metastases
@en
P2093
Andrea Formentini
Doris Henne-Bruns
Gerd Leder
Joern Sträter
Lukasz Filip Grochola
Marko Kornmann
Murray Korc
P2888
P356
10.1007/S00384-008-0550-9
P577
2008-08-31T00:00:00Z